VIROMED MEDICAL NA O.N. (VME) — Net Asset Quality Index
VIROMED MEDICAL NA O.N. (VME) has a Net Asset Quality Index of 75.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €13.91 Million minus total liabilities of €3.44 Million yields net assets of €10.47 Million. A higher index indicates a stronger, lower-leverage balance sheet. See VME defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
VIROMED MEDICAL NA O.N. Net Asset Quality Index Over Time (2022–2025)
This chart shows how VIROMED MEDICAL NA O.N.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 75.3%, representing net assets of €10.47 Million against total assets of €13.91 Million EUR. Also explore VME current and non-current assets for the complete picture of this company's asset base.
Annual Net Asset Quality Index for VIROMED MEDICAL NA O.N. (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for VIROMED MEDICAL NA O.N. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of VIROMED MEDICAL NA O.N..
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.3% | €10.47 Million | €13.91 Million | €3.44 Million | ▲ +6.1 pp |
| 2024 | 69.2% | €9.27 Million | €13.40 Million | €4.13 Million | ▼ -29.0 pp |
| 2023 | 98.2% | €19.97 Million | €20.33 Million | €356.74K | ▼ -0.9 pp |
| 2022 | 99.1% | €20.08 Million | €20.26 Million | €173.57K | — |